JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) - Total Liabilities
Based on the latest financial reports, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has total liabilities worth Rs9.07 Billion INR (≈ $98.05 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore JB Chemicals & Pharmaceuticals Limited operating cash flow efficiency to assess how effectively this company generates cash.
JB Chemicals & Pharmaceuticals Limited - Total Liabilities Trend (2005–2025)
This chart illustrates how JB Chemicals & Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data. Check JBCHEPHARM financial resilience to evaluate the company's liquid asset resilience ratio.
JB Chemicals & Pharmaceuticals Limited Competitors by Total Liabilities
The table below lists competitors of JB Chemicals & Pharmaceuticals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
NCsoft Corp
KO:036570
|
Korea | ₩962.71 Billion |
|
Chunghwa Precision Test Tech Co Ltd
TWO:6510
|
Taiwan | NT$1.17 Billion |
|
Jiangsu Changshu Rural Commercial Bank Co Ltd
SHG:601128
|
China | CN¥369.64 Billion |
|
iRay Technology Co Ltd
SHG:688301
|
China | CN¥5.26 Billion |
|
Endurance Technologies Limited
NSE:ENDURANCE
|
India | Rs43.94 Billion |
|
Gibson Energy Inc.
TO:GEI
|
Canada | CA$3.84 Billion |
|
Centrus Energy Corp.
NYSE MKT:LEU
|
USA | $1.68 Billion |
Liability Composition Analysis (2005–2025)
This chart breaks down JB Chemicals & Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see JB Chemicals & Pharmaceuticals Limited stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.15 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how JB Chemicals & Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for JB Chemicals & Pharmaceuticals Limited (2005–2025)
The table below shows the annual total liabilities of JB Chemicals & Pharmaceuticals Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs8.40 Billion ≈ $90.89 Million |
-21.51% |
| 2024-03-31 | Rs10.71 Billion ≈ $115.80 Million |
-0.25% |
| 2023-03-31 | Rs10.74 Billion ≈ $116.10 Million |
+129.00% |
| 2022-03-31 | Rs4.69 Billion ≈ $50.70 Million |
+10.39% |
| 2021-03-31 | Rs4.25 Billion ≈ $45.93 Million |
+13.08% |
| 2020-03-31 | Rs3.76 Billion ≈ $40.62 Million |
+21.91% |
| 2019-03-31 | Rs3.08 Billion ≈ $33.32 Million |
-3.89% |
| 2018-03-31 | Rs3.21 Billion ≈ $34.67 Million |
+4.01% |
| 2017-03-31 | Rs3.08 Billion ≈ $33.33 Million |
-33.30% |
| 2016-03-31 | Rs4.62 Billion ≈ $49.97 Million |
-6.16% |
| 2015-03-31 | Rs4.92 Billion ≈ $53.25 Million |
+59.76% |
| 2014-03-31 | Rs3.08 Billion ≈ $33.33 Million |
+10.10% |
| 2013-03-31 | Rs2.80 Billion ≈ $30.27 Million |
+22.86% |
| 2012-03-31 | Rs2.28 Billion ≈ $24.64 Million |
-25.98% |
| 2011-03-31 | Rs3.08 Billion ≈ $33.29 Million |
+14.50% |
| 2010-03-31 | Rs2.69 Billion ≈ $29.08 Million |
-3.09% |
| 2009-03-31 | Rs2.77 Billion ≈ $30.00 Million |
-3.77% |
| 2008-03-31 | Rs2.88 Billion ≈ $31.18 Million |
-1.89% |
| 2007-03-31 | Rs2.94 Billion ≈ $31.78 Million |
+68.00% |
| 2006-03-31 | Rs1.75 Billion ≈ $18.91 Million |
+37.57% |
| 2005-03-31 | Rs1.27 Billion ≈ $13.75 Million |
-- |
About JB Chemicals & Pharmaceuticals Limited
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage … Read more